Extension Study Evaluating The Safety And Tolerability of AMX0035
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lahar Mehta, MD
Head, Global Clinical Development
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
46 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospitals Leuven
Leuven, Belgium
- Hospices Civils de Lyon Hôpital Neurologique Pierre Wertheimer Cellule Mutualisée de Recherche Clinique (cmrc)
Bron, France
- Hopital Gabriel Montpied Service de Neurologie
Clermont-Ferrand, France
- Chru de Lille - Hôpital Roger Salengro
Lille, France
- Chu de Limoges - Hôpital Dupuytren
Limoges, France
- Hôpitaux Universitaires de Marseille Timone
Marseille, France
- Chu de Montpellier
Montpellier, France
- Gui de Chauliac
Montpellier, France
- Chu Nice
Nice, France
- Hôpital de la Salpêtrière
Paris, France
- Le Centre Hospitalier Régional Universitaire de Tours
Tours, France
- Uniklinikum Dresden
Dresden, Germany
- Hannover Medical School
Hanover, Germany
- Jena University Hospital
Jena, Germany
- Medizinische Fakultät Mannheim Der Universität Heidelberg
Mannheim, Germany
- University Medical Center Rostock
Rostock, Germany
- Ulm University Medical Centre
Ulm, Germany
- Trinity College Dublin/beaumont Hospital
Dublin, Ireland
- Università Degli Studi Di Bari Aldo Moro
Bari, Italy
- Centro Clinico Nemo
Milan, Italy
- Irccs - Istituto Auxologico Italiano
Milan, Italy
- Irccs - Ospedale San Raffaele
Milan, Italy
- University of Milan Medical School
Milan, Italy
- Azienda Ospedaliero Universitaria Di Modena
Modena, Italy
- Università Degli Studi Della Campania Luigi Vanvitelli
Naples, Italy
- University of Padua
Padova, Italy
- Università Degli Studi Di Bari Aldo Moro
Tricase, Italy
- University of Torino
Turin, Italy
- University Medical Center Utrecht
Utrecht, Netherlands
- Centrum Medyczne Linden
Krakow, Poland
- City Clinic Warsaw
Warsaw, Poland
- Centro Hospitalar Universitário Lisboa-Norte
Lisbon, Portugal
- Hospital Universitari de Bellvitge-Idibell
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
- Hospital Universitario de Basurto
Bilbao, Spain
- Hospital San Rafael
Madrid, Spain
- Biodonostia Health Research Institute; Hospital Universitario Donostia
San Sebastián, Spain
- Hospital Universitario Y Politécnico la Fe
Valencia, Spain
- Karolinska Institutet
Stockholm, Sweden
- Umeå University Hospital
Umeå, Sweden
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Dec 2022
- Primary completion
- 16 Oct 2024
- Completion
- 30 Oct 2024
- Last update posted
- 13 Jan 2025
- Registered enrollment
- 352
- Registry id
- NCT05619783
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.